author-photo

Shoshu Mitsuyama

118

Papers

770

Citations

Citation Trend

Filter By

Papers (91) Sort By

Journal Conference Others

Baseline neutrophil-to-lymphocyte ratio and absolute lymphocyte count in patients with HER2-negative breast cancer treated with eribulin may predict overall survival.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pilot Study of Irinotecan and S-1 (IRIS) for Advanced and Metastatic Breast Cancer.

2020 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (1)
A case of primary extraskeletal osteosarcoma of the breast

2018 Surgical Case Reports
Show All
- Source
- Cite
- Save
Citations (4)
Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors

2018 Breast Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Follicle-Stimulating Hormone and Estradiol Levels in Japanese Women Treated with Toremifene and Anastrozole for Two Years - A Retrospective Analysis of Data from a Prospective Randomized Trial

2018 Gan to kagaku ryoho. Cancer & chemotherapy
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-21-25: The importance of hormone receptor status on biomarker expression and the efficacy of lapatinib plus capecitabine therapy after progression on trastuzumab in HER2 positive recurrent and advanced breast cancer

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Radiofrequency Ablation of Breast Cancer: A Retrospective Study

2017 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (16)
Efficacy and safety of eribulin as first- to third-line treatment in patients with advanced or metastatic breast cancer previously treated with anthracyclines and taxanes

2017 The Breast
Show All
- Source
- Cite
- Save
Citations (18)
Correlation between HER2 related biomarkers (HER2, p95HER2, HER3, PTEN and PIK3CA) and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer refractory to trastuzumab.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review

2016 Surgery Today
Show All
- Source
- Cite
- Save
Citations (19)